Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for DocGo (DCGO) over the last 6 years, with Q3 2025 value amounting to -$30.3 million.

  • DocGo's Net Cash Flow fell 23664.06% to -$30.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.6 million, marking a year-over-year decrease of 17656.36%. This contributed to the annual value of $35.3 million for FY2024, which is 13797.39% up from last year.
  • DocGo's Net Cash Flow amounted to -$30.3 million in Q3 2025, which was down 23664.06% from $4.8 million recorded in Q2 2025.
  • DocGo's 5-year Net Cash Flow high stood at $136.1 million for Q4 2021, and its period low was -$56.0 million during Q3 2023.
  • In the last 5 years, DocGo's Net Cash Flow had a median value of -$540113.0 in 2024 and averaged $2.2 million.
  • In the last 5 years, DocGo's Net Cash Flow soared by 40651684.07% in 2021 and then tumbled by 56315.65% in 2022.
  • DocGo's Net Cash Flow (Quarter) stood at $136.1 million in 2021, then tumbled by 111.94% to -$16.3 million in 2022, then skyrocketed by 125.2% to $4.1 million in 2023, then plummeted by 113.19% to -$540113.0 in 2024, then crashed by 5508.72% to -$30.3 million in 2025.
  • Its last three reported values are -$30.3 million in Q3 2025, $4.8 million for Q2 2025, and -$4.6 million during Q1 2025.